PATH
About us
PATH is an international nonprofit organization that creates sustainable, culturally relevant solutions, enabling communities worldwide to break longstanding cycles of poor health. By collaborating with diverse public- and private-sector partners, PATH helps provide appropriate health technologies and vital strategies that change the way people think and act. PATH’s work improves global health and well-being.
Headquartered in Seattle, Washington, PATH has offices in 31 cities in 22 countries. PATH currently works in more than 70 countries in the areas of health technologies, maternal and child health, reproductive health, vaccines and immunization, and emerging and epidemic diseases.
For more information, please visit www.path.org.
HEALTH TECHNOLOGIES: We bring appropriate, affordable technologies to low-resource settings. Our interventions improve immunization, nutrition, diagnosis, child survival, and maternal and reproductive health.
MATERNAL AND CHILD HEALTH: PATH improves the health of women and children by addressing the leading causes of maternal and child death. Our projects focus on safe birth and newborn care, nutrition, and control of diarrheal disease.
REPRODUCTIVE HEALTH: We work to prevent cervical cancer, advocate for services and supplies, address family-planning needs, prevent sexually transmitted infections, and encourage healthier behaviors.
VACCINES AND IMMUNIZATION: PATH closes gaps in access to livesaving vaccines. Our projects accelerate vaccine research and development, expand access to new vaccines, and strengthen health systems.
EMERGING AND EPIDEMIC DISEASES: PATH reduces the burden of epidemic diseases—including AIDS, malaria, and tuberculosis—as well as emerging threats such as pandemic influenza.
Briefs
Producing a topical medicine for cord care in low- and middle-income countries - local/regional production as the optimal way to increase the availability of quality, affordable medicine to reduce neonatal mortality.
| 0 comments
Briefs
French language version of Production Strategy.
Briefs
Umbilical cord cleansing with 7.1% chlorhexidine digluconate saves newborn lives.
Tools/Guidelines
Frequently asked questions on chlorhexidine for umbilical cord care.
Reports
Working with a consultant, PATH developed four chlorhexidine (CHX) formulations for use during umbilical cord care.
Presentations
The Nepal Context for Child Mortality and Birthing.
Case Studies
Case study prepared for the UN Commission no Life-Saving Commodities for Women's and Children's Health.
Briefs
Summary of the first Latin America and Caribbean Regional Kangaroo Mother Care meeting, held in Santo Domingo, Dominican Republic, December 7-9, 2011.
Reports
On September 14-15 2011, a regional gathering of researchers, program planners, and policy makers from Asia reviewed emerging research and program implementation of chlorhexidine for umbilical cord care. Read the meeting report.
Presentations
During the Chlorhexidine Regional Dissemination Meeting, representatives from PATH present on Ensuring Supply of a Quality Product.
March 12, 2013
Experts in the field of newborn infection spoke about their experiences implementing chlorhexidine as a tool for saving newborn lives.
